Mycobacterium tuberculosis Rv3802c encodes a phospholipase/thioesterase and is inhibited by the antimycobacterial agent tetrahydrolipstatin

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Parker, Sarah K ^a   Barkley, Robert M ^c   Rino, John G ^a   Vasil, Michael L ^b  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CUTINASE; MYCOLIC ACID; PHOSPHOLIPASE A; TETRAHYDROLIPSTATIN; THIOL ESTER HYDROLASE; BACTERIAL PROTEIN; ENZYME INHIBITOR; LACTONE; PHOSPHOLIPASE; RECOMBINANT PROTEIN;

ARTICLE; BACTERIAL GENE; BIOSYNTHESIS; CELL WALL; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; GENE CLUSTER; GENE FUNCTION; GENETIC CONSERVATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; AMINO ACID SEQUENCE; CHEMISTRY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; HYDROLYSIS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; SEQUENCE HOMOLOGY;

ACTINOBACTERIA (CLASS); ESCHERICHIA COLI; MAMMALIA; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; CELL WALL; ENZYME INHIBITORS; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; HYDROLYSIS; LACTONES; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; MYCOLIC ACIDS; PHOSPHOLIPASES; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; THIOLESTER HYDROLASES;

EID: 59249101556     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004281     Document Type: Article

References (45)

1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021.
2. Organization WH (March 2006) Tuberculosis. Fact sheet 104. Geneva, Switzerland: World Health Organization.
3. Barry CE 3rd (2001) Interpreting cell wall 'virulence factors' of Mycobacterium tuberculosis. Trends Microbiol 9: 237-241.
4. Kusner DJ (2005) Mechanisms of mycobacterial persistence in tuberculosis. Clin Immunol 114: 239-247.
5. Brennan PJ (2003) Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb) 83: 91-97.
6. McKinney JD, Honer zu Bentrup K, Munoz-Elias EJ, Miczak A, Chen B, et al. (2000) Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase [see comments]. Nature 406: 735-738.
7. Takayama K, Wang C, Besra GS (2005) Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev 18: 81-101.
8. Lea-Smith DJ, Pyke JS, Tull D, McConville MJ, Coppel RL, et al. (2007) The reductase that catalyzes mycolic motif synthesis is required for efficient attachment of mycolic acids to arabinogalactan. J Biol Chem 282: 11000-11008.
9. Jackson M, Raynaud C, Laneelle MA, Guilhot C, Laurent-Winter C, et al. (1999) Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol Microbiol 31: 1573-1587.
10. Besra GS, Sievert T, Lee RE, Slayden RA, Brennan PJ, et al. (1994) Identification of the apparent carrier in mycolic acid synthesis. Proc Natl Acad Sci U S A 91: 12735-12739.
11. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, et al. (1997) Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276: 1420-1422.
12. Sassetti CM, Boyd DH, Rubin EJ (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48: 77-84.
13. Vissa VD, Brennan PJ (2001) The genome of Mycobacterium leprae: a minimal mycobacterial gene set. Genome Biol 2: REVIEWS1023.
14. Portevin D, De Sousa-D'Auria C, Houssin C, Grimaldi C, Chami M, et al. (2004) A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. Proc Natl Acad Sci U S A 101: 314-319.
15. Portevin D, de Sousa-D'Auria C, Montrozier H, Houssin C, Stella A, et al. (2005) The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth: identification of the carboxylation product and determination of the acyl-CoA carboxylase components. J Biol Chem 280: 8862-8874.
16. Finn RD, Mistry J, Schuster-Bockler B, Griffiths-Jones S, Hollich V, et al. (2006) Pfam: clans, web tools and services. Nucleic Acids Res 34: D247-251.
17. Martinez C, Nicolas A, van Tilbeurgh H, Egloff MP, Cudrey C, et al. (1994) Cutinase, a lipolytic enzyme with a preformed oxyanion hole. Biochemistry 33: 83-89.
18. Devedjiev Y, Dauter Z, Kuznetsov SR, Jones TL, Derewenda ZS (2000) Crystal structure of the human acyl protein thioesterase I from a single X-ray data set to 1.5 A. Structure 8: 1137-1146.
19. Hirokawa T, Boon-Chieng S, Mitaku S (1998) SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 14: 378-379.
20. Mattow J, Siejak F, Hagens K, Schmidt F, Koehler C, et al. (2007) An improved strategy for selective and efficient enrichment of integral plasma membrane proteins of mycobacteria. Proteomics 7: 1687-1701.
21. Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105-132.
22. Parker SK, Curtin KM, Vasil ML (2007) Purification and characterization of mycobacterial phospholipase A: an activity associated with mycobacterial cutinase. J Bacteriol 189: 4153-4160.
23. Kremer L, de Chastellier C, Dobson G, Gibson KJ, Bifani P, et al. (2005) Identification and structural characterization of an unusual mycobacterial monomeromycolyl-diacylglycerol. Mol Microbiol 57: 1113-1126.
24. Egmond MR, de Vlieg J (2000) Fusarium solani pisi cutinase. Biochimie 82: 1015-1021.
25. Wheeler PR, Besra GS, Minnikin DE, Ratledge C (1993) Stimulation of mycolic acid biosynthesis by incorporation of cis-tetracos-5-enoic acid in a cell-wall preparation from Mycobacterium smegmatis. Biochim Biophys Acta 1167: 182-188.
26. Wheeler PR, Ratledge C (1988) Use of carbon sources for lipid biosynthesis in Mycobacterium leprae: a comparison with other pathogenic mycobacteria. J Gen Microbiol 134: 2111-2121.
27. Jackson M, Crick DC, Brennan PJ (2000) Phosphatidylinositol is an essential phospholipid of mycobacteria. J Biol Chem 275: 30092-30099.
28. Browne CD, Hindmarsh EJ, Smith JW (2006) Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor. Faseb J 20: 2027-2035.
29. Deems RA (2000) Interfacial enzyme kinetics at the phospholipid/water interface: practical considerations. Anal Biochem 287: 1-16.
30. Kridel SJ, Axelrod F, Rozenkrantz N, Smith JW (2004) Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res 64: 2070-2075.
31. Richardson RD, Ma G, Oyola Y, Zancanella M, Knowles LM, et al. (2008) Synthesis of novel beta-lactone inhibitors of fatty acid synthase. J Med Chem 51: 5285-5296.
32. Cotes K, Dhouib R, Douchet I, Chahinian H, de Caro A, et al. (2007) Characterization of an exported monoglyceride lipase from Mycobacterium tuberculosis possibly involved in the metabolism of host cell membrane lipids. Biochem J 408: 417-427.
33. West NP, Wozniak TM, Valenzuela J, Feng CG, Sher A, et al. (2008) Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis. Vaccine 26: 3853-3859.
34. Pemble CWt, Johnson LC, Kridel SJ, Lowther WT (2007) Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat. Nat Struct Mol Biol 14: 704-709.
35. Richardson RD, Smith JW (2007) Novel antagonists of the thioesterase domain of human fatty acid synthase. Mol Cancer Ther 6: 2120-2126.
36. Zhang W, Richardson RD, Chamni S, Smith JW, Romo D (2008) Beta-lactam congeners of orlistat as inhibitors of fatty acid synthase. Bioorg Med Chem Lett 18: 2491-2494.
37. Koglin A, Lohr F, Bernhard F, Rogov VV, Frueh DP, et al. (2008) Structural basis for the selectivity of the external thioesterase of the surfactin synthetase. Nature 454: 907-911.
38. Keating TA, Walsh CT (1999) Initiation, elongation, and termination strategies in polyketide and polypeptide antibiotic biosynthesis. Curr Opin Chem Biol 3: 598-606.
39. Linne U, Schwarzer D, Schroeder GN, Marahiel MA (2004) Mutational analysis of a type II thioesterase associated with nonribosomal peptide synthesis. Eur J Biochem 271: 1536-1545.
40. Koglin A, Mofid MR, Lohr F, Schafer B, Rogov VV, et al. (2006) Conformational switches modulate protein interactions in peptide antibiotic synthetases. Science 312: 273-276.
41. Schwarzer D, Mootz HD, Linne U, Marahiel MA (2002) Regeneration of misprimed nonribosomal peptide synthetases by type II thioesterases. Proc Natl Acad Sci U S A 99: 14083-14088.
42. Bennett-Lovsey RM, Herbert AD, Sternberg MJ, Kelley LA (2008) Exploring the extremes of sequence/structure space with ensemble fold recognition in the program Phyre. Proteins 70: 611-625.
43. Etienne G, Laval F, Villeneuve C, Dinadayala P, Abouwarda A, et al. (2005) The cell envelope structure and properties of Mycobacterium smegmatis mc(2)155: is there a clue for the unique transformability of the strain? Microbiology 151: 2075-2086.
44. Gilleron M, Lindner B, Puzo G (2006) MS/MS approach for characterization of the fatty acid distribution on mycobacterial phosphatidyl-myo-inositol mannosides. Anal Chem 78: 8543-8548.
45. Kurioka S, Matsuda M (1976) Phospholipase C assay using p-nitrophenylphosphoryl-choline together with sorbitol and its application to studying the metal and detergent requirement of the enzyme. Anal Biochem 75: 281-289.